Advertisement

Choosing Wisely® in Preventive Medicine

The American College of Preventive Medicine’s Top 5 List of Recommendations
      The Choosing Wisely® initiative is a national campaign led by the American Board of Internal Medicine Foundation, focused on quality improvement and advancing a dialogue on avoiding wasteful or unnecessary medical tests, procedures, and treatments. The American College of Preventive Medicine (ACPM) Prevention Practice Committee is an active participant in the Choosing Wisely project. The committee created the ACPM Choosing Wisely Task Force to lead the development of ACPM’s recommendations with the intention of facilitating wise decisions about the appropriate use of preventive care. After utilizing an iterative process that involved reviewing evidence-based literature, the ACPM Choosing Wisely Task Force developed five recommendations targeted toward overused services within the field of preventive medicine. These include: (1) don’t take a multivitamin, vitamin E, or beta carotene to prevent cardiovascular disease or cancer; (2) don’t routinely perform prostate-specific antigen−based screening for prostate cancer; (3) don’t use whole-body scans for early tumor detection in asymptomatic patients; (4) don’t use expensive medications when an equally effective and lower-cost medication is available; and (5) don’t perform screening for cervical cancer in low-risk women aged 65 years or older and in women who have had a total hysterectomy for benign disease. The Task Force also reviewed some of the barriers to implementing these recommendations, taking into account the interplay between system and environmental characteristics, and identified specific strategies necessary for timely utilization of these recommendations.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Health Policy Briefs. Reducing waste in health care. Health Affairs. Washington, DC. www.healthaffairs.org/healthpolicybriefs/brief.php?brief_id=82. Published December 13, 2012. Accessed October 15, 2015.

        • Berwick D.M.
        • Hackbarth A.D.
        Eliminating waste in U.S. health care.
        JAMA. 2012; 307: 1513-1516https://doi.org/10.1001/jama.2012.362
        • Prasad V.
        • Ioannidis J.P.
        Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices.
        Implement Sci. 2014; 9: 1https://doi.org/10.1186/1748-5908-9-1
        • Schwartz A.L.
        • Landon B.E.
        • Elshaug A.G.
        • Chernew M.E.
        • McWilliams J.M.
        Measuring low-value care in Medicare.
        JAMA Intern Med. 2014; 174: 1067-1076https://doi.org/10.1001/jamainternmed.2014.1541
      2. Agency for Healthcare Research and Quality. Enhancing Use and Quality of Colorectal Cancer Screening. http://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/crcpro-evidence-report.pdf. Published February 2010. Accessed October 15, 2015.

        • Goodwin J.S.
        • Singh A.
        • Reddy N.
        • Riall T.S.
        • Kuo Y.F.
        Overuse of screening colonoscopy in the Medicare population.
        Arch Intern Med. 2011; 171: 1335-1343https://doi.org/10.1001/archinternmed.2011.212
      3. American Board of Internal Medicine (ABIM) Foundation. Choosing Wisely Initiative. www.choosingwisely.org/doctor-patient-lists/. Accessed October 1, 2015.

      4. Centers for Disease Control and Prevention. National Vital Statistics Report−Deaths: Leading Causes for 2010. www.cdc.gov/nchs/data/nvsr/nvsr62/nvsr62_06.pdf. Published December 20, 2013. Accessed October 7, 2015.

        • Fortmann S.P.
        • Burda B.U.
        • Senger C.A.
        • Lin J.S.
        • Whitlock E.P.
        Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force.
        Ann Intern Med. 2013; 159: 824-834https://doi.org/10.7326/0003-4819-159-12-201312170-00729
      5. Nutrition Business Journal. Nutrition Business Journal Supplement Report 2011: an analysis of markets, trends, competition and strategy in the U.S. dietary supplement industry. http://newhope360.com/site-files/newhope360.com/files/uploads/2011/10/TOCEXECSUMM110930.supp%20report%20FINAL-2.pdf. Published October 2013. Accessed October 2015.

        • Bailey R.L.
        • Gahche J.J.
        • Miller P.E.
        • Thomas P.R.
        • Dwyer J.T.
        Why U.S. adults use dietary supplements.
        JAMA Intern Med. 2013; 173: 355-361https://doi.org/10.1001/jamainternmed.2013.2299
        • Albright C.L.
        • Schembre S.M.
        • Steffen A.D.
        • et al.
        Differences by race/ethnicity in older adults’ beliefs about the relative importance of dietary supplements vs prescription medications: results from the SURE Study.
        J Acad Nutr Diet. 2012; 112: 1223-1229https://doi.org/10.1016/j.jand.2012.05.006
        • Moyer V.A.
        Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
        Ann Intern Med. 2012; 157: 120-134https://doi.org/10.7326/0003-4819-157-2-201207170-00459
        • Schröder F.H.
        • Hugosson J.
        • Roobol M.J.
        • et al.
        Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
        Lancet. 2014; 384: 2027-2035https://doi.org/10.1016/S0140-6736(14)60525-0
        • Andriole G.L.
        • Crawford E.D.
        • Grubb R.L.
        • et al.
        Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
        J Natl Cancer Inst. 2012; 104: 125-132https://doi.org/10.1093/jnci/djr500
        • Bell N.
        • Connor Gorber S.
        • Shane A.
        • et al.
        Recommendations on screening for prostate cancer with the prostate-specific antigen test.
        CMAJ. 2014; 186: 1225-1234https://doi.org/10.1503/cmaj.140703
        • Qaseem A.
        • Barry M.J.
        • Denberg T.D.
        • Owens D.K.
        • Shekelle P.
        Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
        Ann Intern Med. 2013; 158: 761-769https://doi.org/10.7326/0003-4819-158-10-201305210-00633
        • Obuchowski N.A.
        • Holden D.
        • Modic M.T.
        • et al.
        Total-body screening: preliminary results of a pilot randomized controlled trial.
        J Am Coll Radiol. 2007; 4: 604-611https://doi.org/10.1016/j.jacr.2007.04.006
        • Furtado C.D.
        • Aguirre D.A.
        • Sirlin C.B.
        • et al.
        Whole-body CT screening: spectrum of findings and recommendations in 1,192 patients.
        Radiology. 2005; 237: 385-394https://doi.org/10.1148/radiol.2372041741
        • Beinfeld M.T.
        • Wittenberg E.
        • Gazelle G.S.
        Cost-effectiveness of whole-body CT screening.
        Radiology. 2005; 234: 415-422https://doi.org/10.1148/radiol.2342032061
        • Hassan C.
        • Pickhardt P.J.
        • Laghi A.
        • et al.
        Impact of whole-body CT screening on the cost-effectiveness of CT colonography.
        Radiology. 2009; 251: 156-165https://doi.org/10.1148/radiol.2511080590
        • Miglioretti D.L.
        • Johnson E.
        • Williams A.
        • et al.
        The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk.
        JAMA Pediatr. 2013; 167: 700-707https://doi.org/10.1001/jamapediatrics.2013.311
        • Berrington de González A.
        • Mahesh M.
        • Kim K.P.
        • et al.
        Projected cancer risks from computed tomographic scans performed in the United States in 2007.
        Arch Intern Med. 2009; 169: 2071-2077https://doi.org/10.1001/archinternmed.2009.440
      6. U.S. Food and Drug Administration. Facts about generic drugs. www.fda.gov/drugs/resourcesforyou/consumers/buyingusingmedicinesafely/understandinggenericdrugs/ucm167991.htm. Accessed October 10, 2015.

        • Allan G.M.
        • Lexchin J.
        • Wiebe N.
        Physician awareness of drug cost: a systematic review.
        PLoS Med. 2007; 4: e283https://doi.org/10.1371/journal.pmed.0040283
        • Shrank W.H.
        • Cox E.R.
        • Fischer M.A.
        • Mehta J.
        • Choudhry N.K.
        Patients’ perceptions of generic medications.
        Health Aff (Millwood). 2009; 28: 546-556https://doi.org/10.1377/hlthaff.28.2.546
        • Hoadley J.F.
        • Merrell K.
        • Hargrave E.
        • Summer L.
        In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions.
        Health Aff (Millwood). 2012; 31: 2266-2275https://doi.org/10.1377/hlthaff.2012.0019
        • Gagne J.J.
        • Choudhry N.K.
        • Kesselheim A.S.
        • et al.
        Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.
        Ann Intern Med. 2014; 161: 400-407https://doi.org/10.7326/M13-2942
        • Moyer V.A.
        Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.
        Ann Intern Med. 2012; 156: 880-891https://doi.org/10.7326/0003-4819-156-12-201206190-00424
        • Tilburt J.C.
        • Wynia M.K.
        • Sheeler R.D.
        • et al.
        Views of U.S. physicians about controlling health care costs.
        JAMA. 2013; 310: 380-388https://doi.org/10.1001/jama.2013.8278
        • Joosen M.C.
        • Van Beurden K.M.
        • Terluin B.
        • et al.
        Improving occupational physicians’ adherence to a practice guideline: feasibility and impact of a tailored implementation strategy.
        BMC Med Educ. 2015; 15: 82https://doi.org/10.1186/s12909-015-0364-8
        • Kennedy P.J.
        • Leathley C.M.
        • Hughes C.F.
        Clinical practice variation.
        Med J Aust. 2010; 193(8): S97-S99
        • Francke A.L.
        • Smit M.C.
        • De Veer A.J.
        • Mistiaen P.
        Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review.
        BMC Med Inform Decis Mak. 2008; 8: 38https://doi.org/10.1186/1472-6947-8-38
      7. U.S. Food and Drug Administration. Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs−summary of FDA survey research results. www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas/DrugMarketingAdvertisingandCommunicationsResearch/ucm152860.pdf. Published November 19, 2004. Accessed October 15, 2015.

        • Chen C.
        • Petterson S.
        • Phillips R.
        • Bazemore A.
        • Mullan F.
        Spending patterns in region of residency training and subsequent expenditures for care provided by practicing physicians for Medicare beneficiaries.
        JAMA. 2014; 312: 2385-2393https://doi.org/10.1001/jama.2014.15973
        • Marewski J.N.
        • Gigerenzer G.
        Heuristic decision making in medicine.
        Dialogues Clin Neurosci. 2012; 14: 77-89
        • Kosko J.
        • Klassen T.P.
        • Bishop T.
        • Hartling L.
        Evidence-based medicine and the anecdote: uneasy bedfellows or ideal couple?.
        Paediatr Child Health. 2006; 11: 665-668
        • Freeman R.J.
        • Cersovsky S.B.
        • Barbour G.
        An evaluation of the delivery of clinical preventive services in the Joint Task Force National Capital Region Medical.
        Mil Med. 2011; 176: 679-684https://doi.org/10.7205/MILMED-D-10-00236
      8. Robert Wood Johnson Foundation. Doing better by doing less: approaches to tackle overuse of services. http://www.rwjf.org/content/dam/farm/reports/issue_briefs/2013/rwjf403697. Published January 2013. Accessed October 15, 2015.

        • Morden N.E.
        • Colla C.H.
        • Sequist T.D.
        • Rosenthal M.B.
        Choosing wisely—the politics and economics of labeling low-value services.
        N Engl J Med. 2014; 370: 589-592https://doi.org/10.1056/NEJMp1314965
        • Levinson W.
        • Roter D.L.
        • Mullooly J.P.
        • Dull V.T.
        • Frankel R.M.
        Physician-patient communication. The relationship with malpractice claims among primary care physicians and surgeons.
        JAMA. 1997; 277: 553-559https://doi.org/10.1001/jama.1997.03540310051034
        • Armstrong P.W.
        Do guidelines influence practice?.
        Heart. 2003; 89: 349-352https://doi.org/10.1136/heart.89.3.349
        • Ghali J.K.
        • Massie B.M.
        • Mann D.L.
        • Rich M.W.
        Heart failure guidelines, performance measures, and the practice of medicine: mind the gap.
        J Card Fail. 2011; 17: 90
        • Masoudi F.A.
        • Peterson E.D.
        • Anderson J.L.
        • Bonow R.O.
        • Jacobs A.K.
        Clinical guidelines and performance measures; responsible guidance and accountability.
        J Am Coll Cardiol. 2010; 56: 2081-2083https://doi.org/10.1016/j.jacc.2010.10.004
        • Probst C.A.
        • Shaffer V.A.
        • Chan Y.R.
        The effect of defaults in an electronic health record on laboratory test ordering practices for pediatric patients.
        Health Psychol. 2013; 32: 995-1002https://doi.org/10.1037/a0032925
      9. Consumer Reports Health. Whole-body scans to screen for cancer: they don’t help find cancer—and may do more harm than good. http://consumerhealthchoices.org/wp-content/uploads/2015/08/ChoosingWiselyBodyScansACPM-ER.pdf. Published August 2015. Accessed February 7, 2016.

      10. Consumer Reports Health. Dietary supplements to prevent heart disease or cancer: they don’t help—and some can be harmful. http://consumerhealthchoices.org/wp-content/uploads/2015/08/ChoosingWiselySupplementsACPM-ER.pdf. Published August 2015 Accessed February 7, 2016.